EJC News Focus
Advances in the treatment of early breast cancer have revolutionised the outlook for many patients. But an important minority - around one in three - still progress to the advanced stage, which is treatable, but almost never curable. Women and men with advanced breast cancer have an illness associated with significant symptoms and one for which, in contrast to the early setting, there are few recognised therapeutic standards. An international, multidisciplinary group has now produced the first consensus guidelines, and they were presented at the European Breast Cancer Conference (Vienna, Austria; 21-24 March 2012).
Lead author Fatima Cardoso (Champalimaud Cancer Center, Lisbon, Portugal) explains why she strongly believes that widespread implementation of these guidelines will lead to better survival outcomes in advanced breast cancer.
Issue Highlights
-
Type 2 diabetes mellitus and colorectal cancer: Meta-analysis on sex-specific differencesJune 2012 (Vol. 48 | No. 9 | Pages 1269-1282)
-
Lung cancer in never smokers – A reviewJune 2012 (Vol. 48 | No. 9 | Pages 1299-1311)
-
Long term renal toxicity of ifosfamide in adult patients – 5June 2012 (Vol. 48 | No. 9 | Pages 1326-1331)
year data
-
Mature results of a phase II trial on individualised accelerated radiotherapy based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancer21 May 2012
-
NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality21 May 2012
-
Higher prevalence of sexual dysfunction in colon and rectal cancer survivors compared with the normative population: A population-based study21 May 2012
-
Cisplatin and gemcitabine administered every two weeks in patients with locally advanced or metastatic urothelial carcinoma and impaired renal function18 May 2012
-
Quality-of-life among head and neck cancer survivors at one year after treatment – A systematic review14 May 2012







